Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. SC 13D Stake Beneficial Ownership Report
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Other events
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 424B3 Offering Prospectus
  7. 424B3 Offering Prospectus
  8. 10-Q Report Quarterly Report
  9. 8-K Event Other events
  10. 8-K Event Delisting notice
  11. 8-K Event Executive or director change
  12. 424B3 Offering Prospectus
  13. 424B3 Offering Prospectus
  14. 424B3 Offering Prospectus
  15. 424B3 Offering Prospectus
  16. 10-Q Report Quarterly Report
  17. SC 13G Stake Amended Statement of Ownership
  18. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  19. 424B3 Offering Prospectus
  20. EFFECT Other Notice of Effectiveness

Page 36 of 42 · 833 filings